Sep 2026
Imeglimin halts cyclophosphamide-induced ovarian injury: a dual modulation of TLR4/NF-κB/NLRP3-driven inflammation and AMPK/SIRT1/PGC-1α pathways.
Reham H. Mohyeldin, Ehab E. Sharata, Mahmoud Abdelnaser et al.
· Naunyn-Schmiedeberg's Archiv... · 0 citations